Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

PME PEER ANALYSIS

Pro Medicus Ltd — metric-by-metric comparison with peers and the industry median

PMEPro Medicus Ltd

🇦🇺 Australia · AU · Healthcare · Health Information Services

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Health Information Services

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
PMEIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
PME-31.8%BTSG+219.0%HQY-4.8%VEEV-31.6%TXG+217.4%WAY-38.3%
Year-to-Date (YTD)
PME-4.3%BTSG+87.4%HQY+5.9%VEEV-13.9%TXG+131.9%WAY-27.3%
1-Year
Split-adjusted
PME-31.8%FPH+1.1%RMD-19.0%SIG-5.5%CSL-48.8%SHL-15.2%
Year-to-Date (YTD)
PME-4.3%FPH+2.6%RMD-12.1%SIG-3.4%CSL-27.3%SHL-1.4%

Key Metric Comparison

P/E

Lower is better
PME93.98BTSG50.11HQY35.73VEEV33.90TXG—WAY36.85Median 42.02

ROE

Higher is better
PME76.8%BTSG16.9%HQY11.1%VEEV13.9%TXG-3.0%WAY3.6%Median 2.7%

Net Margin

Higher is better
PME97.6%BTSG2.3%HQY17.3%VEEV28.4%TXG-3.5%WAY10.9%Median 1.5%

Revenue Growth

Higher is better
PME30.3%BTSG21.0%HQY7.6%VEEV16.2%TXG2.3%WAY18.6%Median 7.1%

P/E

Lower is better
PME93.98FPH42.22RMD20.97SIG—CSL29.96SHL20.04Median 42.02

ROE

Higher is better
PME76.8%FPH23.3%RMD25.2%SIG-1.6%CSL7.7%SHL6.4%Median 2.7%

Net Margin

Higher is better
PME97.6%FPH20.0%RMD27.4%SIG-0.3%CSL9.2%SHL5.2%Median 1.5%

Revenue Growth

Higher is better
PME30.3%FPH4.8%RMD10.5%SIG45.7%CSL4.8%SHL11.4%Median 7.1%

All Metrics

Valuation
MetricPMEBTSGHQYVEEVTXGWAYInd. Median
P/E93.9850.1135.7333.90●—36.8542.02
P/B56.717.854.034.375.961.18●2.48
EV/EBITDA115.8432.8919.5519.0147.1014.44●16.13
P/S91.681.14●6.169.627.604.022.42
Financial Health
MetricPMEBTSGHQYVEEVTXGWAYInd. Median
Current Ratio6.22●1.743.444.745.901.761.83
Debt/Equity1.1%●136.4%48.1%1.4%10.0%37.7%22.0%
NetDebt/EBITDA-1.163.441.57-5.55●-4.913.21-0.01
Profitability
MetricPMEBTSGHQYVEEVTXGWAYInd. Median
Net Margin97.6%●2.3%17.3%28.4%-3.5%10.9%1.5%
ROE76.8%●16.9%11.1%13.9%-3.0%3.6%2.7%
ROA56.7%●5.1%6.9%11.1%-2.4%2.4%1.4%
EBITDA Margin78.4%●3.9%34.3%39.2%14.6%35.8%12.4%
Growth + Dividend
MetricPMEBTSGHQYVEEVTXGWAYInd. Median
Rev. Growth30.3%●21.0%7.6%16.2%2.3%18.6%7.1%
NI Growth138.8%441.5%●89.4%20.6%—383.6%23.6%
Div. Yield0.3%—————0.8%
Payout24.5%—————9.6%
Valuation
MetricPMEFPHRMDSIGCSLSHLInd. Median
P/E93.9842.2220.97—29.9620.04●42.02
P/B56.719.294.8738.332.241.26●2.48
EV/EBITDA115.8423.8314.27774.7410.359.80●16.13
P/S91.688.465.736.632.661.04●2.42
Financial Health
MetricPMEFPHRMDSIGCSLSHLInd. Median
Current Ratio6.22●2.313.011.592.571.011.83
Debt/Equity1.1%●6.9%13.0%15.8%67.4%85.8%22.0%
NetDebt/EBITDA-1.16●-0.39-0.382.822.223.78-0.01
Profitability
MetricPMEFPHRMDSIGCSLSHLInd. Median
Net Margin97.6%●20.0%27.4%-0.3%9.2%5.2%1.5%
ROE76.8%●23.3%25.2%-1.6%7.7%6.4%2.7%
ROA56.7%●17.3%18.6%-0.9%3.8%3.3%1.4%
EBITDA Margin78.4%●34.9%39.1%0.9%32.8%17.3%12.4%
Growth + Dividend
MetricPMEFPHRMDSIGCSLSHLInd. Median
Rev. Growth30.3%4.8%10.5%45.7%●4.8%11.4%7.1%
NI Growth138.8%●-11.6%15.9%—-39.4%-1.1%23.6%
Div. Yield0.3%1.6%8.0%●0.5%2.5%5.2%0.8%
Payout24.5%53.9%22.4%-114.0%103.1%96.9%9.6%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PME

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.